Hypertrophic pachymeningitis in a patient with ANCA negative granulomatosis with polyangiitis: A case report

Leavitt, 1990, The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis, Arthritis Rheum, 33, 1101, 10.1002/art.1780330807 Comarmond, 2014, Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment, Autoimmun Rev, 13, 1121, 10.1016/j.autrev.2014.08.017 Luna, 2015, Central nervous system involvement of granulomatosis with polyangiitis: clinical–radiological presentation distinguishes different outcomes, Rheumatology, 54, 424, 10.1093/rheumatology/keu336 Reinhold-Keller, 2000, An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients, Arthritis Rheum, 43, 1021, 10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J Nishino, 1993, Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic, Ann Neurol, 33, 4, 10.1002/ana.410330103 Katrib, 1998, Meningeal involvement in Wegener's granulomatosis, J Rheumatol, 25, 1009 Dash, 2015, Clinico-radiological spectrum and outcome in idiopathic hypertrophic pachymeningitis, J Neurol Sci, 350, 51, 10.1016/j.jns.2015.02.013 Brüggemann, 2010, Cranial pachymeningitis: a rare neurological syndrome with heterogeneous aetiology, J Neurol Neurosurg Psychiatry, 81, 294, 10.1136/jnnp.2008.160457 Kupersmith, 2004, Idiopathic hypertrophic pachymeningitis, Neurology, 62, 686, 10.1212/01.WNL.0000113748.53023.B7 Masson, 1993, Cranial pachymeningitis of unknown cause. A study of seven cases, Neurology, 1329, 10.1212/WNL.43.7.1329 Dörr, 2008, Treatment-resistant chronic headaches and focal pachymeningitis in a 46-year-old man: a rare presentation of Wegener's granulomatosis, Lancet Neurol, 7, 368, 10.1016/S1474-4422(08)70064-4 Shobha, 2008, Hypertrophic cranial pachymeningitis in countries endemic for tuberculosis: diagnostic and therapeutic dilemmas, J Clin Neurosci, 15, 418, 10.1016/j.jocn.2007.03.003 Salvarani, 2007, Primary central nervous system vasculitis: analysis of 101 patients, Ann Neurol, 62, 442, 10.1002/ana.21226 Hoffman, 1992, Wegener granulomatosis: an analysis of 158 patients, Ann Intern Med, 116, 488, 10.7326/0003-4819-116-6-488 Kumamoto, 2016, Hypertrophic pachymeningitis as a delayed complication of granulomatosis with polyangiitis, Intern Med, 55, 413, 10.2169/internalmedicine.55.5434 Seror, 2006, Central nervous system involvement in wegener granulomatosis, Medicine (Baltimore), 85, 53, 10.1097/01.md.0000200166.90373.41 Frosch, 2004, Wegener granulomatosis in childhood and adolescence, Eur J Pediatr, 163, 425, 10.1007/s00431-004-1464-3 Di Comite, 2006, Meningeal involvement in Wegener's granulomatosis is associated with localized disease, Clin Exp Rheumatol, 24, S60 Mukhtyar, 2009, EULAR recommendations for the management of primary small and medium vessel vasculitis, Ann Rheum Dis, 68, 310, 10.1136/ard.2008.088096 Jennette, 2013, 2012 revised international chapel hill consensus conference nomenclature of vasculitides, Arthritis Rheum, 65, 1, 10.1002/art.37715 Yokoseki, 2014, Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody, Brain J Neurol, 137, 520, 10.1093/brain/awt314 Osgood, 2014, Starvation marrow – gelatinous transformation of bone marrow, J Community Hosp Intern Med Perspect, 4 Sen, 2003, Clinical profile in gelatinous bone marrow transformation, J Assoc Physicians India, 51, 585 Böhm, 2000, Gelatinous transformation of the bone marrow: the spectrum of underlying diseases, Am J Surg Pathol, 24, 56, 10.1097/00000478-200001000-00007 Smoleńska Ż, 2018, Hypertrophic pachymeningitis as an important neurological complication of granulomatosis with polyangiitis, Reumatologia, 56, 399, 10.5114/reum.2018.80719